Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.

PHASE4RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 13, 2025

Primary Completion Date

August 11, 2027

Study Completion Date

August 11, 2027

Conditions
Persistent Spinal Pain Syndrome
Interventions
DEVICE

Pain pump

Spinal catheter place under local anesthesia.

DRUG

Bupivacain 0.625%/Fentanyl 2mcg/ml

A solution containing fentanyl 2 mcg/mL and bupivacaine 0.625 mg/mL at an infusion rate of 0.5 ml/hr.

DEVICE

Spinal Cord Stimulator (SCS)

"Two spinal cord stimulation leads will then be advanced under fluoroscopy to the target area, typically around T7-T9 in the posterior epidural space.~Currently, there are six manufacturers of spinal cord stimulation devices with implanted programmable generators or receivers."

Trial Locations (1)

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER